PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany.\', \'Fraunhofer Cluster of Excellence Immune Mediated Diseases, CIMD, 60596 Frankfurt am Main, Germany.\', \'Institute of Medical Virology, University Hospital Frankfurt/Main, Goethe University, Paul-Ehrlich-Str. 40, 60596 Frankfurt am Main, Germany.\', \'Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Discovery Research ScreeningPort, 22525 Hamburg, Germany.\', \'Reckitt Healthcare Ltd., Dansom Lane South, Kingston Upon Hull HU8 7DS, UK.\', \'Health Professions Education Unit, Hull York Medical School, University of York, Heslington, York YO10 5DD, UK.\', \'Pharmazentrum Frankfurt/ZAFES, Department of Clinical Pharmacology, Goethe-University Hospital Frankfurt am Main, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 104910.3390/ijms23031049
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 35162972
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all